Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T19:15:53.397Z.
Calculation as of: 2026-10-06T19:15:53.397Z.
Quote observation: 2026-10-06T19:14:51.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d0d3cab615a00e4182867faf392a700f3c2ff11ca91232cb78ad2c83a49f3690
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Bone Biologics Corporation
Market Cap
$850879.00
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$858334.00
EV/FCF Ratio
N/A
TTM Avg
13238.43x
3Y Avg
13238.43x
5Y Avg
13238.43x
Market Cap
$747565.00
EV/FCF Ratio
N/A
TTM Avg
837938.26x
3Y Avg
5687338.31x
5Y Avg
5687338.31x
Market Cap
$1.02M
EV/FCF Ratio
N/A
TTM Avg
60793.51x
3Y Avg
60793.51x
5Y Avg
60793.51x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bone Biologics Corporation (BBLG) | $850879.00 | N/A | N/A | N/A | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $844430.00 | N/A | N/A | N/A | N/A |
| Sunshine Biopharma, Inc. (SBFM)vs › | $858334.00 | N/A | 13238.43x | 13238.43x | 13238.43x |
| Decoy Therapeutics Inc. (DCOY)vs › | $840509.00 | N/A | N/A | N/A | N/A |
| Ridgetech, Inc. (RDGT)vs › | $827005.00 | N/A | 3.75x | 3.71x | 2.08x |
| GlucoTrack, Inc. (GCTK)vs › | $901902.00 | N/A | N/A | N/A | N/A |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $747565.00 | N/A | 837938.26x | 5687338.31x | 5687338.31x |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | N/A | 60793.51x | 60793.51x | 60793.51x |
| CDT Equity Inc. (CDT)vs › | $678241.00 | N/A | 2.87x | 2.87x | 2.87x |
| Clearmind Medicine Inc. (CMND)vs › | $1.08M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
